Whey protein isolate (WPI) solutions (100 g L -1 protein) were subjected to a heat-treatment of 80 ºC for 10 min. Un-heated and heat-treated WPI solutions were hydrolysed with Corolase ® PP at pilot-scale to either 5 or 10 % degree of hydrolysis (DH). Hydrolysates were subsequently processed via cascade membrane fractionation using 0.14 μm, 30, 10, 5 and 1 kDa molecular weight cut-off membranes. The 
Page -8 -of 31 A/S, Skanderborg, Denmark). For hydrolysates at 5 % and 10 % DH which were derived from heat-treated WPI, intial fractionation was via microfiltration (MF). MF was accomplished with three Tami Isoflux™ ceramic membranes (25 x 1178 In all cases, the subsequent permeate stream (~300 L) prepared above was then subjected to ultrafiltration (UF) using the same GEA model F unit fitted with two Koch KMS HFK™-328 spiral wound membranes. These membranes have a nominal MWCO of 5 kDa and a total surface area (TMA) of 11.2 m 2 . The 5 kDa permeate stream (~300 L) was then processed (at 50 ºC) on the GEA model F plant fitted with two 1 kDa MWCO Alpha Laval UF-ETNA spiral wound membranes (TMA 11.2 m 2 , 95 x 965 mm, Alpha Laval AB, Lund, Sweden) to a VCF of 3, whereupon feed volume was returned to 300 L with RO and UF was carried out to a final VCF of 7. A feed recirculation rate of 1500 L h -1 at 1 bar and membrane inlet pressure of 5 bar were maintained throughout processing. All process streams, with the exception of 1 kDa retentates and permeates, were dehydrated in a pilot scale Anhydro Lab 3 spray drier using the conditions as described above. The 1 kDa retentates and permeates were further concentrated (to~35 % total solids) before spray drying, as outlined above, in a Anhydro F1 Lab single effect falling film evaporator. As an example, the process flow diagram for the production of fractionated powders from hydrolysed (to 10 % DH) heat-treated WPI is shown in Appendix A (Fig. A. 1 ). Final volumes prior to concentration and total solids levels are provided in Appendix B for all four processes (Fig. B. 1 ).
Particle size, chromatography and compositional analysis of control and heatedtreated WPI and hydrolysates
Particle size analysis was carried out using a Malvern Mastersizer MSS Protein content was determined by micro-Kjeldahl on a Foss Kjeltec TM 8400
(Foss, Hillerød, Denmark). The procedure was modified from Koops et al. 1975 (Koops, Klomp, & Elgersma, 1975 where a conversion factor of 6.38 was used in accordance with Merrill, 1973 (Merrill et al., 1973 . Ash was determined gravimetrically through modification of the International Dairy Federation (IDF) method (International Dairy Federation, 2008) where ≥ 1 g of powder was weighed to the nearest 0.1 mg. Moisture content was determined through heating at 102°C ± 2°C
for 2 hrs according to the respective IDF method (International Dairy Federation, 2004) . Lactose was determined using a food analysis lactose/galactose test kit (Roche Diagnostics GmbH, Mannheim, Germany). Determination of free-amine (NH 2 ) groups was determined via the 2,4,6-trinitrobenzene 1-sulfonic acid (TNBS) methodology of Adler-Nissen (1979) modified by O'Loughlin et al. (2012) .
Angiotensin-I-coverting enzyme inhibition assay
ACE was extracted from rabbit lung acetone powder reconstituted in 100 mM sodium borate buffer according to the method of Cushman & Cheung (1971) .
Subsequently, the inhibition of ACE activity was measured by HPLC through modification of the method of Jiang et al. (Jiang, Tian, Brodkorb, & Huo, 2010) .
Hippuryl-histine-leucine (Hipp-his-leu), 1mM, was dissolved in 50 mM sodium 
Total iron concentration and ferrous chelating activity determination
The concentration of total iron present in the WPI, the hydrolysates and their for 1 min. The reaction was initiated by the addition of 100 μL of 5 mM ferrozine and the samples vortexed again and allowed to stand at room temperature for 10 min. The absorbance was read at 562 nm as described previously. EDTA-Na 2 was used as a positive control for chelation. The ferrous chelating activity was then determined according to the following formula;
Where: A 0 was the absorbance of the control at 562 nm, A 1 was the absorbance of the sample at 562 nm and A 2 was the absorbance of the blank at 562 nm.
retentate powders which had a relatively low protein concentration, a high percentage of soluble material > 30 kDa and a high ash content (Table 1) . Interestingly, the percentage soluble material 10 -5 kDa increased in the unhydrolysed substrate, from 3.8 ± 0.9 to 26.1 ± 0.9 %, upon heat-treatment. This was due to the increased insolubility and presence of large aggregates upon heating which resulted in only the soluble fraction being available for distribution analysis.
As expected the higher level of hydrolysis at 10 % DH of unheated control WPI favored an increased percentage soluble material < 1 kDa (Tables 1 and 2 ). Due to the higher DH, a 10 kDa MWCO membrane was utilized to optimize the fractionation process and the 10 kDa retentate of 10 % DH hydrolysate had~50 % soluble material > 30 kDa (Table 2) . Also, hydrolysis of heat-treated WPI to 10 % DH resulted in an increase in the percentage soluble material to 86 % (results not shown).
The most noteworthy difference between the 10 % DH hydrolysates of the control and heat-treated WPI was the increase, by a factor of~1.12, in soluble material < 1 kDa in the heat-treated 1 kDa permeate compared to the corresponding control permeate.
Hydrolysis of the heat-treated WPI resulted in an increase in the percentage soluble material to~57 % (results not shown). These results are in agreement with a previous study on the molecular mass distribution of aggregated dispersions which were hydrolysed using a similar laboratory scale process (O'Loughlin et al., 2013b) . Higher IC 50 values, and lower potency ACE inhibition was observed following concentration of higher M w peptide material in the 30/10 kDa and 0.14 μm retentates compared to the un-fractionated whole hydrolysates. Correspondingly, the lowest IC 50 value (0.23 ± 0.07 g protein L -1 ) was observed for the 1 kDa permeate of heat-treated WPI hydrolysed to 10 % DH (Table 3) . However, while generally the lower M w fractions possessed the highest ACE inhibitory activity, the correlation between average M w and inhibition activity was poor (r = 0.524, P < 0.01, results not shown).
This was exemplified in the case of the 5 kDa retentate fractions from the control and heat-treated hydrolysates, which, while possessing similar M w distributions (Table 1) , presented significant (P < 0.05) differences in ACE inhibitory activity (Table 3) .
From , 1997) . However, from that study, the 1 kDa permeates possessed lower ACE inhibitory activities than the 3 kDa permeates of the respective hydrolysates. The cumulative beneficial effect of both prior heat-treatment and higher DH is highlighted by the 10 % DH hydrolysate of the heat-treated WPI which had the highest ACE inhibition of the un-fractionated hydrolysates assayed (76.2 ± 1.2 %, Table 3 ).
Total iron and ferrous chelating capability of WPI, hydrolysates and fractions
Total iron content of the control WPI starting material (~ 228 μg L The ferrous chelating capability, determined at 1 g L -1 , exhibited significant differences (P < 0.05) between the samples (Tables 3) with hydrolysis resulting in an increase in the chelating capability of WPI by a factor of ≥ 2. Generally, greater iron chelation (~55.7 %) was measured in the lower M w fractionated samples. The ferrous chelating capability was higher for the 10 % DH hydrolysates compared to equivalent 5 % DH samples, irrespective of prior heat-treatment (Table 3) . Interestingly, the whole hydrolysates of the heat-treated WPI samples had a lower percentage chelating ability (at 1 g L -1 ) than equivalent unheated control hydrolysates at both 5 and 10 % DH. Overall, the highest percentage iron chelating ability (~55.7 %) was observed in the 1 kDa permeate of the 10 % DH heat-treated WPI (Table 3) .
The concentration of sample required for the chelation of 50 % of ferrous iron under the assay conditions (CC 50 ) followed a similar trend as those seen in the % chelating ability. The lowest CC 50 values were observed for the 1 kDa retentates and permeates of both the control and heat-treated WPI hydrolysates (Table 3) . Generally, lower CC 50 values were seen with the 10 % DH samples and there appeared to be no discernable effect of prior heat-treatment of the substrate on iron chelation. While the 1 kDa permeates of the 5 % DH hydrolysates subjected to heat-treatment possessed lower iron CC 50 values, in the 10 % DH samples the difference was not statistically significant (P < 0.05). Overall, the highest iron CC 50 value was in the 30 kDa retentate of the unheated control 5 % DH hydrolysate (4.50 g L -1 ), with the lowest value in the 1 kDa permeate of the heat-treated 10 % DH hydrolysate (0.83 g L -1 , Table 3 ).
There was a strong positive correlation (r = 0.918, P < 0.01) between the average M w and the concentration needed to chelate 50 % of the iron (CC 50 ) in solution ( 
Conclusions
This pilot-scale study validates the findings of earlier laboratory experiments demonstrating altered kinetic, molecular and physico-chemical characteristics of
hydrolysates obtained following pre-hydrolysis heat-treatments on WPI. Of particular significance was the enhancement of ACE inhibitory activity present in WPI hydrolysates. This study demonstrated an increased ACE inhibitory activity as a direct result of prior heat-treatment of the WPI substrate and enrichment of ACE inhibitory activity in the lower M w fractions. The ferrous chelating capability of the hydrolysate fractions was directly correlated with the average M w of the peptides within the samples. There is a possibility that the bio-functionalities of these samples reflect the cumulative effect of more than one peptide in the fraction. Future work is required in the isolation and characterisation the active ingredients within these hydrolysates and fractions. Nevertheless, this work demonstrates the process scale up of thermallydenatured whey protein hydrolysis highlighting the concomitant consequences for downstream bio-functionality.
Appendices

Appendix A
The process flow diagram for the heat-treatment, enzymatic hydrolysis and subsequent membrane cascade fractionation of heat-treated (80 ºC for 10 min) WPI hydrolysed to 10 % DH is shown in Fig. A. 1.
Appendix B
Total solids and final volume determinations for all four processes are exhibited in Fig. B . 1.
Financial support
The work 
